Ontogeny of hepatic and renal systemic clearance pathways in infants: part II

Jane Alcorn1, Patrick J McNamara

  • 1Division of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington 40536, USA.

Clinical Pharmacokinetics
|October 31, 2002
PubMed

Insights

A new mathematical model estimates drug clearance in infants by analyzing liver enzyme and kidney function maturation. This Infant Scaling Factor (ISF) helps predict how well babies eliminate medications compared to adults.

Area of Science:

  • Pharmacokinetics
  • Pediatric Pharmacology
  • Drug Metabolism

Background:

  • Infant drug clearance mechanisms undergo significant postnatal maturation.
  • Understanding these changes is crucial for safe and effective pediatric drug dosing.

Purpose of the Study:

  • To develop a mathematical model for predicting drug clearance in infants up to 6 months old.
  • To estimate an Infant Scaling Factor (ISF) reflecting the maturation of hepatic and renal clearance pathways.

Main Methods:

  • Utilized age-specific in vitro hepatic microsomal activity and in vivo glomerular filtration data.
  • Developed a model to predict an age- and pathway-specific Infant Scaling Factor (ISF).
  • Validated the model by predicting infant systemic clearance for drugs eliminated by specific CYP enzymes or glomerular filtration.

Main Results:

  • The model reasonably predicted clearance for CYP1A2 and CYP3A4, but less accurately for CYP2D6 and CYP2C.
  • Renal clearance predictions were reasonable, suggesting adult values (normalized to bodyweight) may approximate infant values.
  • The ISF directly correlates adult clearance with an infant's drug elimination capacity.

Conclusions:

  • The developed model provides a valuable tool for estimating infant drug clearance.
  • Further model refinement is needed for certain cytochrome P450 enzymes.
  • Adult renal clearance values normalized to bodyweight may serve as reasonable predictors for infants.

Related Concept Videos

Renal Drug Clearance: Overview01:06

Renal Drug Clearance: Overview

Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance01:09

Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance

Hepatic clearance refers to the volume of blood cleared of a drug by the liver per unit of time. It plays a crucial role in drug metabolism and elimination. While hepatic clearance is commonly estimated by subtracting renal clearance from total body clearance, other pathways, such as pulmonary or biliary clearance, may also contribute. However, these pathways are generally less significant than hepatic and renal clearance.
Most drugs undergo restrictive clearance, which is proportional to the...
Hepatic Drug Clearance: Role of Transporters01:14

Hepatic Drug Clearance: Role of Transporters

In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...